Youcare Pharmaceutical Group Co. Ltd. A (688658) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.051x

Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥173.51 Million ≈ $25.39 Million USD) by net assets (CN¥3.43 Billion ≈ $502.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Youcare Pharmaceutical Group Co. Ltd. A to measure how many days the company can operate on defensive assets alone.

Youcare Pharmaceutical Group Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Haixin Group Co Ltd A SHG:600851	0.015x
Seegene Inc KQ:096530	0.037x
Shenzhen Centralcon Investment Holding Co Ltd SHE:000042	0.767x
Sunrise Group Co Ltd SHE:002752	0.004x
ARS Pharmaceuticals, Inc NASDAQ:SPRY	-0.381x
Gansu Yatai Industrial Development Co Ltd SHE:000691	-0.880x
Cangzhou Dahua Co Ltd SHG:600230	0.018x
Scholastic Corporation NASDAQ:SCHL	0.079x

Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)

The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Youcare Pharmaceutical Group Co. Ltd. A (688658) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.43 Billion ≈ $502.48 Million	CN¥344.00 Million ≈ $50.34 Million	0.100x	-18.05%
2024-12-31	CN¥3.58 Billion ≈ $524.59 Million	CN¥438.24 Million ≈ $64.13 Million	0.122x	-44.01%
2023-12-31	CN¥3.60 Billion ≈ $526.45 Million	CN¥785.49 Million ≈ $114.94 Million	0.218x	+820.23%
2022-12-31	CN¥4.00 Billion ≈ $584.90 Million	CN¥-121.17 Million ≈ $-17.73 Million	-0.030x	-123.11%
2021-12-31	CN¥3.93 Billion ≈ $574.66 Million	CN¥515.24 Million ≈ $75.40 Million	0.131x	-32.57%
2020-12-31	CN¥3.59 Billion ≈ $524.73 Million	CN¥697.66 Million ≈ $102.09 Million	0.195x	-32.65%
2019-12-31	CN¥1.12 Billion ≈ $164.59 Million	CN¥324.94 Million ≈ $47.55 Million	0.289x	+26.35%
2018-12-31	CN¥842.76 Million ≈ $123.32 Million	CN¥192.70 Million ≈ $28.20 Million	0.229x	-24.22%
2017-12-31	CN¥711.86 Million ≈ $104.17 Million	CN¥214.81 Million ≈ $31.43 Million	0.302x	--

About Youcare Pharmaceutical Group Co. Ltd. A

SHG:688658 China Biotechnology

Market Cap

$867.89 Million

CN¥5.93 Billion CNY

Market Cap Rank

#9692 Global

#2566 in China

Share Price

CN¥13.18

Change (1 day)

-1.05%

52-Week Range

CN¥13.18 - CN¥34.33

All Time High

CN¥34.33